CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82 | -99.9% | 3,645 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | 0.0% | 3,770 | +1.7% | 0.00% | -33.3% |
| Q2 2022 | $84,000 | -23.6% | 3,706 | -25.6% | 0.00% | +200.0% |
| Q1 2022 | $110,000 | +307.4% | 4,984 | +297.8% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,253 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +525.0% | 1,153 | +639.1% | 0.00% | – |
| Q2 2021 | $4,000 | – | 156 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 275 | -68.6% | 0.00% | – |
| Q3 2018 | $12,000 | +140.0% | 876 | +172.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |